Literature DB >> 7076113

The aminopyrine breath test and serum bile acids reflect histologic severity in chronic hepatitis.

P S Monroe, A L Baker, J F Schneider, P S Krager, P D Klein, D Schoeller.   

Abstract

To determine whether the aminopyrine breath test (ABT) and serum bile acid concentrations reflect histologic severity of chronic hepatitis, 56 patients were prospectively evaluated with liver biopsies and ABTs, and the results were compared to results of standard liver chemistry tests; 44 of these patients also had fasting and 2-hr postprandial serum bile acid measurements. Mean values for the ABT were significantly lower, and serum bile acids were significantly higher in patients with chronic active hepatitis with bridging or cirrhosis than in patients with mild chronic active hepatitis or chronic persistent hepatitis. Thirty of 35 patients with bridging or cirrhosis had ABTs less than 5.7% (mean of controls -2 S.D.) and 21 of 25 with mild chronic active hepatitis or chronic persistent hepatitis had values greater than 5.7% (sensitivity 0.86, specificity 0.84). Fasting and 2-hr postprandial bile acids were also more sensitive than standard chemistries in identifying patients with bridging or cirrhosis. Thus, the ABT and serum bile acids reflect histologic severity in chronic hepatitis patients and may be helpful in selecting patients for liver biopsy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076113     DOI: 10.1002/hep.1840020305

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  13 in total

1.  Influence of low-dose oral contraceptives, alcohol, and grapefruit on.

Authors:  H Van Vlierberghe; F Van Durme; H Verdievel; M Dhont; M de Vos; A Elewaut
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

Review 2.  Liver function tests.

Authors:  M F Laker
Journal:  BMJ       Date:  1990-08-04

3.  Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.

Authors:  J Reichen; B Egger; N Ohara; T B Zeltner; T Zysset; A Zimmermann
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

4.  Parameters of microsomal and cytosolic liver function but not of liver perfusion predict portal vein velocity in noncirrhotic patients with chronic hepatitis C.

Authors:  C Herold; P Berg; D Kupfal; D Becker; D Schuppan; E G Hahn; H T Schneider
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

5.  Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity.

Authors:  M Abei; E Tanaka; N Tanaka; Y Matsuzaki; T Ikegami; A Ishikawa; T Osuga
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

6.  Drug disposition in patients with HBsAg-positive chronic liver disease.

Authors:  J P Villeneuve; M J Thibeault; M Ampelas; H Fortunet-Fouin; L LaMarre; J Côté; G Pomier-Layrargues; P M Huet
Journal:  Dig Dis Sci       Date:  1987-07       Impact factor: 3.199

7.  Determination of individual serum bile acids in chronic liver diseases: fasting levels and results of oral chenodeoxycholic acid tolerance test.

Authors:  Y Adachi; T Nanno; T Itoh; Y Kurumi; K Yamazaki; Y Sawada; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1988-08

8.  Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis?

Authors:  Christoph Herold; Sabine Regn; Marion Ganslmayer; Matthias Ocker; Eckhart G Hahn; Detlef Schuppan
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

9.  Evaluation of [14C]aminopyrine breath test, peripheral clearance of [99mTc]EHIDA, and serum bile acid levels in liver function and disease.

Authors:  A Nikopoulos; E Giannoulis; I Doutsos; P Grammaticos; A Tourkantonis; C Arvanitakis
Journal:  Dig Dis Sci       Date:  1992-11       Impact factor: 3.199

10.  [13C]Aminopyrine breath test detects altered liver metabolism caused by low-dose oral contraceptives.

Authors:  A R Opekun; P D Klein; D Y Graham
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.